Sep 3, 2010
             
Welcome 
Search  in  
Patient Site»
 
 
 
 Register Here  Username  Password  forgot password
 
      Updated: Sep 3, 2010 
Impact of adding cilostazol or clopidogrel to standard aspirin and clopidogrel treatment in T2DM patients and coronay artery disease undergoing percutaneous coronary intervention   
Clopidotrel resistance in T2DM patients is overcome by adjunctive treatment with cilostazol on standard dual antiplatelet therapy
Sort Out III substudy: Comparative study of clinical outcome of zotarolimus-eluting versus sirolimus-eluting stents in patients with diabetes mellitus   
ZES is inferior to SES, with incremental differences in patients with diabetes as compared to patients without diabetes
Changes of glucose, insulin levels in patients with AH and MS during 6-month course of antihypertensive treatment   
Telmisartan significantly improves state insulin resistance in patients with arterial hypertension and metabolic syndrome
Comparison of prognosis of insulin-requiring DM patients with non-insulin dependent DM patients presenting with AMI in the drug-eluting stent era   
Insulin-requiring DM patients reported higher in hospital cardiac death and total major cardiac events during the study
Rosuvastatin exhibits long term beneficial vascular effects in hypertensive patients with dyslipidemia   
Rosuvastatin also improved L/H ratio and anti-inflammatory action in these patients
PL-ACS Registry: Effect of Diabetes mellitus on in-hospital and 3-years mortality in patients with and without ST-segment elevation myocardial infarction complicated by CS.   
DM determines higher in-hospital and 3-years mortality in these patients
Effect of rosuvastatin on fasting and non fasting hypertriglyceridemia and an inflammatory parameter hsCRP   
Rosuvastatin decreases both fasting and non fasting triglyceride in patients with CHD
Combination of diet and short-term rosuvastatin therapy on inflammatory parameters and LDL in patients with metabolic syndrome   
Short-term treatment with rosuvastatin decreases inflammation in patients with metabolic syndrome
     
Predictors of glycaemic fluctuation and its association with outcomes in critically ill patients   
Wide glycaemic fluctuation is an independent predictor of mortality in critically ill patients
Changes in insulin secretion after lifestyle intervention may be mediated via alterations in GIP secretion from intestinal K-cells   
Improved insulin secretion is a consequence of elevated â-cell function, in older obese diabetic patients.
Efficacy and safety of biphasic insulin aspart 70/30 vs insulin glargine in type 2 diabetics   
BIAsp 30 + metformin achieved similar HbA1c and lower PPG compared with those receiving glargine + metformin + secretagogues
Strong Heart Study: Relationship between depression and glycemic control in American   
Individuals with diabetes have higher rates of depression than those without diabetes
Insulin initiation with twice-daily biphasic insulin aspart 30 in T2DM subjects inadequately controlled by human insulins   
BIAsp 30 treatment improved both glycaemic control and patients' satisfaction in the study population.
Individualized exercise program to prevent diabetes in obese pregnant women   
The results of the study showed that the intervention was feasible and prompted a modest increase in physical activity
Effects of pioglitazone on renal, systemic and hormonal responses to changes in sodium intake in individuals prone to insulin resistance   
Pioglitazones increases diurnal proximal sodium retention in diabetic and hypertensive individuals which results in fluid retention
Influence of oral antidiabetic drugs on hyperglycemic response to foods in type 2 diabetics   
Determination of glucose response curves and subject-related glycemic index, using the continuous glucose monitoring system, is a potential means for the evaluation of efficacy of OAD treatment
Individualized exercise program to prevent diabetes in obese pregnant women   
The results of the study showed that the intervention was feasible and prompted a modest increase in physical activity
Identifying biomarkers that can reliably identify biopsy-proven diabetic nephropathy   
Urine proteome analysis may allow non-invasive differential diagnosis of diabetic nephropathy
     
Liraglutide: a new kid on the block  
Insulin glargine: Effectively reduced blood glucose with less hypoglycemia  
Cardiovascular Risk Factors in Type II Diabetic patients  
Negative Pressure Wound Therapy: Effectiveness In Diabetic Foot  
Treatment of diabetic macular edema: Intravitreal steroid versus photocoagulation   
     
Biospherics acquires global patent rights to develop Tagatose as a trigylcerides therapy    
NOXXON to commence Phase Ib Clinical Trial Of MCP-1 Inhibitor NOX-E36 in August 2010    
Artificial pancreas to control glucose levels in type 1 diabetics could be commercially available in a few years    
Spherix announces positive interim results of phase 3 trial of a novel, oral, antidiabetic compound - D-tagatose    
Archive >>
     
EASD 2010, 46th Annual Meeting
Sep 20, 2010 - Sep 24, 2010.
Stockholm

 

Insulin-sensitizing strategy in the high-risk subjects who were on insulin at baseline decreased the risk of death, vascular events or severe hypoglycemia.
True
False
Not Sure
 
• Related Article

About Us  |  Disclaimer  |  Privacy Statement  |  Advertising info  |  Contact Us ©Copyright 2000-2010 Centrix Healthcare Inc - All Rights Reserved.